Mace 2014.

Trial name or title	Trial of use of vapocoolant spray to decrease the pain of peripheral IV line placement in adults
Methods	Prospective randomized placebo‐controlled trial
Participants	Adults > 21years undergoing peripheral IV at a large urban tertiary care hospital ED 112 participants: "demographics and vital signs were not significantly different between the two groups" Mean age placebo group 48 vs 54 in vapocoolant group Male placebo 43% vs vapocoolant 40% Caucasian placebo 40% vs vapocoolant 42% African American placebo 60% vs vapocoolant 58%
Interventions	Intervention group vapocoolant spray (1,1,1,3,3, pentafluoropropane and 1,1,1,2 tetrafluoropropane, Gabauer Pain‐Ease); n = 78 Placebo normal saline spray n = 77
Outcomes	Pain measured on a 10‐point scale at 2 points Post spray Post spray and venipuncture. Skin checklist and adverse events self reported
Starting date
Contact information	Sahron Mace, Cleveland
Notes	Aims to collect data on 300 participants in total